UniProt ID | TMCO1_HUMAN | |
---|---|---|
UniProt AC | Q9UM00 | |
Protein Name | Calcium load-activated calcium channel {ECO:0000305|PubMed:27212239} | |
Gene Name | TMCO1 {ECO:0000312|HGNC:HGNC:18188} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 188 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Golgi apparatus membrane Multi-pass membrane protein . The first transmembrane region is required for localization to the endoplasmic reticulum (PubMed:27212239). A publication reported |
|
Protein Description | Calcium-selective channel required to prevent calcium stores from overfilling, thereby playing a key role in calcium homeostasis. [PubMed: 27212239 In response to endoplasmic reticulum overloading, assembles into a homotetramer, forming a functional calcium-selective channel, regulating the calcium content in endoplasmic reticulum store] | |
Protein Sequence | MSTMFADTLLIVFISVCTALLAEGITWVLVYRTDKYKRLKAEVEKQSKKLEKKKETITESAGRQQKKKIERQEEKLKNNNRDLSMVRMKSMFAIGFCFTALMGMFNSIFDGRVVAKLPFTPLSYIQGLSHRNLLGDDTTDCSFIFLYILCTMSIRQNIQKILGLAPSRAATKQAGGFLGPPPPSGKFS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSTMFADTL ------CCCCHHHHH | 28.69 | 24043423 | |
3 | Phosphorylation | -----MSTMFADTLL -----CCCCHHHHHH | 18.27 | 24043423 | |
8 | Phosphorylation | MSTMFADTLLIVFIS CCCCHHHHHHHHHHH | 21.75 | 24043423 | |
15 | Phosphorylation | TLLIVFISVCTALLA HHHHHHHHHHHHHHH | 10.32 | 24043423 | |
18 | Phosphorylation | IVFISVCTALLAEGI HHHHHHHHHHHHCCC | 20.41 | 24043423 | |
26 | Phosphorylation | ALLAEGITWVLVYRT HHHHCCCCEEEEEEC | 22.00 | 24043423 | |
31 | Phosphorylation | GITWVLVYRTDKYKR CCCEEEEEECHHHHH | 12.02 | 24043423 | |
40 (in isoform 1) | Ubiquitination | - | 46.67 | 21890473 | |
40 (in isoform 2) | Ubiquitination | - | 46.67 | 21890473 | |
40 | Ubiquitination | TDKYKRLKAEVEKQS CHHHHHHHHHHHHHH | 46.67 | 21906983 | |
45 | Ubiquitination | RLKAEVEKQSKKLEK HHHHHHHHHHHHHHH | 66.11 | - | |
53 | Ubiquitination | QSKKLEKKKETITES HHHHHHHHHHHHHHH | 46.60 | - | |
54 | Ubiquitination | SKKLEKKKETITESA HHHHHHHHHHHHHHH | 71.77 | - | |
56 | Phosphorylation | KLEKKKETITESAGR HHHHHHHHHHHHHHH | 41.92 | 25262027 | |
58 | Phosphorylation | EKKKETITESAGRQQ HHHHHHHHHHHHHHH | 31.16 | 29255136 | |
60 | Phosphorylation | KKETITESAGRQQKK HHHHHHHHHHHHHHH | 27.63 | 23401153 | |
60 (in isoform 2) | Phosphorylation | - | 27.63 | 25849741 | |
91 | 2-Hydroxyisobutyrylation | SMVRMKSMFAIGFCF HHHHHHHHHHHHHHH | 1.88 | - | |
97 (in isoform 2) | Ubiquitination | - | 2.21 | 21890473 | |
105 | 2-Hydroxyisobutyrylation | FTALMGMFNSIFDGR HHHHHHHHHHHHCCC | 5.55 | - | |
109 | Phosphorylation | MGMFNSIFDGRVVAK HHHHHHHHCCCEEEE | 9.04 | 18691976 | |
111 | Phosphorylation | MFNSIFDGRVVAKLP HHHHHHCCCEEEECC | 17.34 | 19007248 | |
116 | Ubiquitination | FDGRVVAKLPFTPLS HCCCEEEECCCCCHH | 45.12 | 21890473 | |
116 (in isoform 1) | Ubiquitination | - | 45.12 | 21890473 | |
120 | Phosphorylation | VVAKLPFTPLSYIQG EEEECCCCCHHHHCC | 22.75 | - | |
141 (in isoform 2) | Ubiquitination | - | 3.17 | 21890473 | |
153 (in isoform 2) | Ubiquitination | - | 9.10 | 21890473 | |
160 | Ubiquitination | SIRQNIQKILGLAPS HHHHHHHHHHCCCCC | 35.78 | 21906983 | |
160 (in isoform 1) | Ubiquitination | - | 35.78 | 21890473 | |
167 (in isoform 2) | Ubiquitination | - | 29.01 | 21890473 | |
171 | Phosphorylation | LAPSRAATKQAGGFL CCCCCHHHHHCCCCC | 23.78 | - | |
172 (in isoform 1) | Ubiquitination | - | 33.16 | 21890473 | |
172 | Ubiquitination | APSRAATKQAGGFLG CCCCHHHHHCCCCCC | 33.16 | 2190698 | |
184 | Phosphorylation | FLGPPPPSGKFS--- CCCCCCCCCCCC--- | 61.46 | 30266825 | |
186 (in isoform 1) | Ubiquitination | - | 46.93 | 21890473 | |
186 | Ubiquitination | GPPPPSGKFS----- CCCCCCCCCC----- | 46.93 | 21890473 | |
188 | Phosphorylation | PPPSGKFS------- CCCCCCCC------- | 42.68 | 25463755 | |
235 | Phosphorylation | ------------------------------------------------------ ------------------------------------------------------ | 18691976 | ||
239 | Phosphorylation | ---------------------------------------------------------- ---------------------------------------------------------- | 18691976 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMCO1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMCO1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMCO1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AT5F1_HUMAN | ATP5F1 | physical | 26344197 | |
CY1_HUMAN | CYC1 | physical | 26344197 | |
DHB12_HUMAN | HSD17B12 | physical | 26344197 | |
ODPB_HUMAN | PDHB | physical | 26344197 | |
RAB1B_HUMAN | RAB1B | physical | 26344197 | |
RPN1_HUMAN | RPN1 | physical | 26344197 | |
QCR8_HUMAN | UQCRQ | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
213980 | Craniofacial dysmorphism, skeletal anomalies and mental retardation syndrome (CFSMR) | |||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60 AND SER-188, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-184 AND SER-188,AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND MASSSPECTROMETRY. |